Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Interferon alpha 2b topical - Helix BioPharma

X
Drug Profile

Interferon alpha 2b topical - Helix BioPharma

Alternative Names: AP-001; Interferon-alpha-2b - Helix BioPharma

Latest Information Update: 14 Jan 2021

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Helix BioPharma
  • Class Antineoplastics; Antivirals; Interferons; Recombinant proteins
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Phase II Cervical dysplasia; Genital warts

Most Recent Events

  • 14 Jan 2021 BetterLife Pharma announces intention to file an IND with the US FDA by Q1 2022
  • 14 Jan 2021 BetterLife Pharma plans a pre-IND meeting with the US FDA in Q3 2021
  • 01 Sep 2020 Altum Pharmaceuticals has been acquired by BetterLife Pharma

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top